KR101900520B1 - 복합 조성물 - Google Patents

복합 조성물 Download PDF

Info

Publication number
KR101900520B1
KR101900520B1 KR1020137014178A KR20137014178A KR101900520B1 KR 101900520 B1 KR101900520 B1 KR 101900520B1 KR 1020137014178 A KR1020137014178 A KR 1020137014178A KR 20137014178 A KR20137014178 A KR 20137014178A KR 101900520 B1 KR101900520 B1 KR 101900520B1
Authority
KR
South Korea
Prior art keywords
paracetamol
ibuprofen
composition
combined
pain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020137014178A
Other languages
English (en)
Korean (ko)
Other versions
KR20140025314A (ko
Inventor
하틀리 캠벨 앳킨슨
Original Assignee
에이에프티 파마슈티칼스 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46024668&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR101900520(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 에이에프티 파마슈티칼스 리미티드 filed Critical 에이에프티 파마슈티칼스 리미티드
Publication of KR20140025314A publication Critical patent/KR20140025314A/ko
Application granted granted Critical
Publication of KR101900520B1 publication Critical patent/KR101900520B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
KR1020137014178A 2010-11-04 2011-10-26 복합 조성물 Active KR101900520B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NZ58901110 2010-11-04
NZ589011 2010-11-04
PCT/NZ2011/000226 WO2012060719A1 (en) 2010-11-04 2011-10-26 A combination composition

Publications (2)

Publication Number Publication Date
KR20140025314A KR20140025314A (ko) 2014-03-04
KR101900520B1 true KR101900520B1 (ko) 2018-09-19

Family

ID=46024668

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020137014178A Active KR101900520B1 (ko) 2010-11-04 2011-10-26 복합 조성물

Country Status (28)

Country Link
US (6) US20130225685A1 (enExample)
EP (1) EP2635269B1 (enExample)
JP (2) JP2013541583A (enExample)
KR (1) KR101900520B1 (enExample)
CN (2) CN107519159A (enExample)
AU (1) AU2011324137B2 (enExample)
BR (1) BR112013010829B8 (enExample)
CA (1) CA2814057C (enExample)
CL (1) CL2013001250A1 (enExample)
CO (1) CO6771406A2 (enExample)
CY (1) CY1123398T1 (enExample)
DK (1) DK2635269T3 (enExample)
ES (1) ES2742373T3 (enExample)
HR (1) HRP20191489T1 (enExample)
HU (1) HUE045442T2 (enExample)
LT (1) LT2635269T (enExample)
MX (2) MX367209B (enExample)
MY (1) MY160572A (enExample)
NZ (1) NZ609727A (enExample)
PH (2) PH12013500689A1 (enExample)
PL (1) PL2635269T3 (enExample)
PT (1) PT2635269T (enExample)
RS (1) RS59258B1 (enExample)
RU (2) RU2707089C2 (enExample)
SG (1) SG189319A1 (enExample)
SI (1) SI2635269T1 (enExample)
SM (1) SMT201900481T1 (enExample)
WO (1) WO2012060719A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2742373T3 (es) 2010-11-04 2020-02-14 Aft Pharmaceuticals Ltd Una composición de combinación
US9072710B2 (en) 2012-03-16 2015-07-07 Cumberland Pharmaceuticals Inc. Injectable ibuprofen formulation
WO2016008546A1 (en) 2014-07-18 2016-01-21 Everbright Pharmaceuticals S.A.R.L. Aqueous formulation comprising paracetamol and ibuprofen
CN106999454A (zh) * 2014-10-06 2017-08-01 坎伯兰医药品股份有限公司 共同施用静脉内布洛芬和对乙酰氨基酚以治疗疼痛
WO2018192664A1 (en) 2017-04-20 2018-10-25 Hyloris Developments Sa METHOD FOR PREPARING A COMPOSITION WITH A LOW DISSOLVED OXYGEN CONTENT, COMPRISING ACETAMINOPHEN, AND OPTIONALLY ONE OR MORE NSAIDs, AND A COMPOSITION OBTAINED THEREOF
EP4480495A3 (en) * 2017-07-10 2025-06-18 Gel Cap Technologies, LLC Dual release dosage form capsule and methods, devices and systems for making same
US11197830B2 (en) 2019-02-27 2021-12-14 Aft Pharmaceuticals Limited Pharmaceutical composition containing acetaminophen and ibuprofen
US11568752B2 (en) * 2020-01-28 2023-01-31 David Clark Company Incorporated Gateway retrieval alert device for aircraft pushback operations
WO2023281089A2 (en) 2021-07-08 2023-01-12 Krka, D.D., Novo Mesto Pharmaceutical composition comprising naproxen and paracetamol
GR1010769B (el) * 2023-07-27 2024-09-18 Ιουλια Κλεωνος Τσετη Υδατικο διαλυμα ιβουπροφαινης για χρηση σε ενδοφλεβια χορηγηση
IL324832A (en) 2023-06-02 2026-01-01 Ioulia Tseti Pharmaceutical composition comprising ibuprofen
GR1010809B (el) * 2023-09-13 2024-10-25 Ιουλια Τσετη Υδατικο διαλυμα ιβουπροφαινης παρακεταμολης για χρηση σε ενδοφλεβια χορηγηση

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010044681A1 (en) * 2008-10-14 2010-04-22 Aft Pharmaceuticals Limited A medicinal product and treatment

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997020551A1 (en) * 1995-12-05 1997-06-12 Adcock Ingram Limited Pharmaceutical composition comprising a skeletal muscle relaxant, a non-steroidal antiinflammatory agent and an analgesic
JP5185488B2 (ja) * 2001-11-02 2013-04-17 カンバーランド ファーマシューティカルズ，インコーポレーテッド ２−（４−イソブチルフェニル）プロピオン酸の医薬組成物
KR101113005B1 (ko) * 2003-03-21 2012-02-24 맥네일-피피씨, 인코포레이티드 비-스테로이드계 항염증성 약물 투여법
BRPI0512756A (pt) * 2004-07-07 2008-04-08 Aft Pharmaceuticals Ltd composição farmacêutica de combinação para o tratamento de dor, método de controle de dor, uso de uma composição e embalagem farmacêutica incluindo comprimidos ou cápsulas
KR20060072839A (ko) * 2004-12-23 2006-06-28 김경태 아세트아미노펜과 이부프로펜을 이용하여 통증조절과 해열작용을 하는 주사제
US7934627B2 (en) * 2005-10-13 2011-05-03 Alcoa Inc. Apparatus and method for high pressure extrusion with molten aluminum
ES2651444T3 (es) * 2006-10-20 2018-01-26 Johnson & Johnson Consumer Inc. Combinación de acetaminofeno con ibuprofeno para el tratamiento del dolor
WO2008079818A2 (en) * 2006-12-21 2008-07-03 Soluprin Pharmaceuticals, Inc. Intravenous administration of water soluble analgesic formulations
US20090264530A1 (en) * 2008-04-16 2009-10-22 Nickell Robert P Combined nsaid and acetaminophen formulation and method
AU2010224063B2 (en) * 2009-03-12 2015-04-16 Cumberland Pharmaceuticals Inc Administration of intravenous ibuprofen
NZ604009A (en) * 2010-07-07 2015-03-27 Aft Pharmaceuticals Ltd A combination composition comprising ibuprofen and paracetamol
ES2742373T3 (es) 2010-11-04 2020-02-14 Aft Pharmaceuticals Ltd Una composición de combinación
CN106999454A (zh) * 2014-10-06 2017-08-01 坎伯兰医药品股份有限公司 共同施用静脉内布洛芬和对乙酰氨基酚以治疗疼痛

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010044681A1 (en) * 2008-10-14 2010-04-22 Aft Pharmaceuticals Limited A medicinal product and treatment

Also Published As

Publication number Publication date
US20160235695A1 (en) 2016-08-18
LT2635269T (lt) 2019-09-10
PH12013500689A1 (en) 2013-05-27
US11896567B2 (en) 2024-02-13
PT2635269T (pt) 2019-09-04
CA2814057A1 (en) 2012-05-10
MX2013005113A (es) 2013-06-03
EP2635269B1 (en) 2019-05-22
HUE045442T2 (hu) 2019-12-30
US20250134839A1 (en) 2025-05-01
MX367209B (es) 2019-07-22
JP6353577B2 (ja) 2018-07-04
PH12021550804A1 (en) 2022-02-14
ES2742373T3 (es) 2020-02-14
SMT201900481T1 (it) 2019-11-13
BR112013010829A2 (pt) 2016-08-16
US20190029982A1 (en) 2019-01-31
RU2707089C2 (ru) 2019-11-22
AU2011324137A1 (en) 2013-05-02
US20240207210A1 (en) 2024-06-27
CY1123398T1 (el) 2021-10-29
RU2015103107A (ru) 2015-06-20
CN107519159A (zh) 2017-12-29
US11446266B2 (en) 2022-09-20
PL2635269T3 (pl) 2019-11-29
RU2013123646A (ru) 2014-12-10
HRP20191489T1 (hr) 2019-11-15
BR112013010829B1 (pt) 2021-12-21
CL2013001250A1 (es) 2013-08-30
EP2635269A4 (en) 2014-09-17
RS59258B1 (sr) 2019-10-31
US20130225685A1 (en) 2013-08-29
JP2017132791A (ja) 2017-08-03
KR20140025314A (ko) 2014-03-04
AU2011324137B2 (en) 2015-05-07
CA2814057C (en) 2022-02-01
DK2635269T3 (da) 2019-08-26
NZ609727A (en) 2015-07-31
US12220392B2 (en) 2025-02-11
JP2013541583A (ja) 2013-11-14
SI2635269T1 (sl) 2019-10-30
CO6771406A2 (es) 2013-10-15
WO2012060719A1 (en) 2012-05-10
SG189319A1 (en) 2013-05-31
CN103298464A (zh) 2013-09-11
EP2635269A1 (en) 2013-09-11
US20230000805A1 (en) 2023-01-05
RU2015103107A3 (enExample) 2018-08-20
MY160572A (en) 2017-03-15
BR112013010829B8 (pt) 2022-01-04

Similar Documents

Publication Publication Date Title
US12220392B2 (en) Combination composition
KR20180100309A (ko) 데옥시콜산 및 이의 염을 사용한 축적된 지방의 치료 방법
AU2009304002B2 (en) A medicinal product and treatment
KR20170066549A (ko) 통증 치료를 위한 이부프로펜과 아세트아미노펜의 공동 정맥 투여
JP2019506397A5 (enExample)
AU2011274652B2 (en) A combination composition comprising ibuprofen and paracetamol
CN108430581A (zh) 用于利扎曲普坦的药物组合物
AU2019287097A1 (en) Pharmaceutical composition for treating chronic constipation
CA2516458A1 (en) Use of kahalalide compounds for the manufacture of a medicament for the treatment of psoriasis
ES2668943T3 (es) Composición farmacéutica para tratar eyaculación precoz y método de tratamiento de la eyaculación precoz
CN117243947A (zh) 瑞香素及包含其的组合在制备糖尿病并发症药物中的应用
CN117243948A (zh) 包含瑞香素的组合物在制备风湿性关节炎药物中的应用
GB2602123A (en) Composition for procedural sedation and use thereof
RU2015147233A (ru) Способы лечения, включающие эсликарбазепин или эсликарбазепина ацетат

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

D13-X000 Search requested

St.27 status event code: A-1-2-D10-D13-srh-X000

D14-X000 Search report completed

St.27 status event code: A-1-2-D10-D14-srh-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T13-X000 Administrative time limit extension granted

St.27 status event code: U-3-3-T10-T13-oth-X000

AMND Amendment
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E601 Decision to refuse application
PE0601 Decision on rejection of patent

St.27 status event code: N-2-6-B10-B15-exm-PE0601

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T13-X000 Administrative time limit extension granted

St.27 status event code: U-3-3-T10-T13-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T13-X000 Administrative time limit extension granted

St.27 status event code: U-3-3-T10-T13-oth-X000

AMND Amendment
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PX0901 Re-examination

St.27 status event code: A-2-3-E10-E12-rex-PX0901

PX0701 Decision of registration after re-examination

St.27 status event code: A-3-4-F10-F13-rex-PX0701

X701 Decision to grant (after re-examination)
GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

J204 Request for invalidation trial [patent]
PJ0204 Invalidation trial for patent

St.27 status event code: A-5-5-V10-V11-apl-PJ0204

J204 Request for invalidation trial [patent]
PJ0204 Invalidation trial for patent

St.27 status event code: A-5-5-V10-V11-apl-PJ0204

P22-X000 Classification modified

St.27 status event code: A-4-4-P10-P22-nap-X000

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

S14-X000 Exclusive voluntary license recorded

St.27 status event code: A-4-4-S10-S14-lic-X000

J301 Trial decision

Free format text: TRIAL NUMBER: 2023100003210; TRIAL DECISION FOR INVALIDATION REQUESTED 20230927

Effective date: 20250624

Free format text: TRIAL NUMBER: 2023100003209; TRIAL DECISION FOR INVALIDATION REQUESTED 20230927

Effective date: 20250624

Free format text: TRIAL NUMBER: 2023100003208; TRIAL DECISION FOR INVALIDATION REQUESTED 20230927

Effective date: 20250624

PJ1301 Trial decision

St.27 status event code: A-5-5-V10-V15-crt-PJ1301

Decision date: 20250624

Appeal event data comment text: Appeal Kind Category : Invalidation, Appeal Ground Text : 1900520

Appeal request date: 20230927

Appellate body name: Patent Examination Board

Decision authority category: Office appeal board

Decision identifier: 2023100003208

Decision date: 20250624

Appeal event data comment text: Appeal Kind Category : Invalidation, Appeal Ground Text : 1900520

Appeal request date: 20230927

Appellate body name: Patent Examination Board

Decision authority category: Office appeal board

Decision identifier: 2023100003210

Decision date: 20250624

Appeal event data comment text: Appeal Kind Category : Invalidation, Appeal Ground Text : 1900520

Appeal request date: 20230927

Appellate body name: Patent Examination Board

Decision authority category: Office appeal board

Decision identifier: 2023100003209

J301 Trial decision

Free format text: TRIAL NUMBER: 2023100003296; TRIAL DECISION FOR INVALIDATION REQUESTED 20231011

Effective date: 20250626

Free format text: TRIAL NUMBER: 2023100003295; TRIAL DECISION FOR INVALIDATION REQUESTED 20231011

Effective date: 20250626

Free format text: TRIAL NUMBER: 2023100003294; TRIAL DECISION FOR INVALIDATION REQUESTED 20231011

Effective date: 20250626

PJ1301 Trial decision

St.27 status event code: A-5-5-V10-V15-crt-PJ1301

Decision date: 20250626

Appeal event data comment text: Appeal Kind Category : Invalidation, Appeal Ground Text : 1900520

Appeal request date: 20231011

Appellate body name: Patent Examination Board

Decision authority category: Office appeal board

Decision identifier: 2023100003295

Decision date: 20250626

Appeal event data comment text: Appeal Kind Category : Invalidation, Appeal Ground Text : 1900520

Appeal request date: 20231011

Appellate body name: Patent Examination Board

Decision authority category: Office appeal board

Decision identifier: 2023100003297

Decision date: 20250626

Appeal event data comment text: Appeal Kind Category : Invalidation, Appeal Ground Text : 1900520

Appeal request date: 20231011

Appellate body name: Patent Examination Board

Decision authority category: Office appeal board

Decision identifier: 2023100003296

Decision date: 20250626

Appeal event data comment text: Appeal Kind Category : Invalidation, Appeal Ground Text : 1900520

Appeal request date: 20231011

Appellate body name: Patent Examination Board

Decision authority category: Office appeal board

Decision identifier: 2023100003294

PJ2001 Appeal

St.27 status event code: A-5-5-V10-V12-crt-PJ2001

V12 Court appeal requested

Free format text: ST27 STATUS EVENT CODE: A-5-5-V10-V12-CRT-PJ2001 (AS PROVIDED BY THE NATIONAL OFFICE)

PJ1301 Trial decision

St.27 status event code: A-5-5-V10-V15-crt-PJ1301

Decision date: 20251022

Appeal event data comment text: Appeal Kind Category : Invalidation, Appeal Ground Text : 1900520

Appeal request date: 20231011

Appellate body name: Patent Examination Board

Decision authority category: Office appeal board

Decision identifier: 2023100003280

Decision date: 20251022

Appeal event data comment text: Appeal Kind Category : Invalidation, Appeal Ground Text : 1900520

Appeal request date: 20231011

Appellate body name: Patent Examination Board

Decision authority category: Office appeal board

Decision identifier: 2023100003292

Decision date: 20251022

Appeal event data comment text: Appeal Kind Category : Invalidation, Appeal Ground Text : 1900520

Appeal request date: 20231011

Appellate body name: Patent Examination Board

Decision authority category: Office appeal board

Decision identifier: 2023100003291

Decision date: 20251022

Appeal event data comment text: Appeal Kind Category : Invalidation, Appeal Ground Text : 1900520

Appeal request date: 20231011

Appellate body name: Patent Examination Board

Decision authority category: Office appeal board

Decision identifier: 2023100003290

Decision date: 20251022

Appeal event data comment text: Appeal Kind Category : Invalidation, Appeal Ground Text : 1900520

Appeal request date: 20231011

Appellate body name: Patent Examination Board

Decision authority category: Office appeal board

Decision identifier: 2023100003289

Decision date: 20251022

Appeal event data comment text: Appeal Kind Category : Invalidation, Appeal Ground Text : 1900520

Appeal request date: 20231011

Appellate body name: Patent Examination Board

Decision authority category: Office appeal board

Decision identifier: 2023100003288

Decision date: 20251022

Appeal event data comment text: Appeal Kind Category : Invalidation, Appeal Ground Text : 1900520

Appeal request date: 20231011

Appellate body name: Patent Examination Board

Decision authority category: Office appeal board

Decision identifier: 2023100003287

Decision date: 20251022

Appeal event data comment text: Appeal Kind Category : Invalidation, Appeal Ground Text : 1900520

Appeal request date: 20231011

Appellate body name: Patent Examination Board

Decision authority category: Office appeal board

Decision identifier: 2023100003286

Decision date: 20251022

Appeal event data comment text: Appeal Kind Category : Invalidation, Appeal Ground Text : 1900520

Appeal request date: 20231011

Appellate body name: Patent Examination Board

Decision authority category: Office appeal board

Decision identifier: 2023100003285

Decision date: 20251022

Appeal event data comment text: Appeal Kind Category : Invalidation, Appeal Ground Text : 1900520

Appeal request date: 20231011

Appellate body name: Patent Examination Board

Decision authority category: Office appeal board

Decision identifier: 2023100003284

Decision date: 20251022

Appeal event data comment text: Appeal Kind Category : Invalidation, Appeal Ground Text : 1900520

Appeal request date: 20231011

Appellate body name: Patent Examination Board

Decision authority category: Office appeal board

Decision identifier: 2023100003283

Decision date: 20251022

Appeal event data comment text: Appeal Kind Category : Invalidation, Appeal Ground Text : 1900520

Appeal request date: 20231011

Appellate body name: Patent Examination Board

Decision authority category: Office appeal board

Decision identifier: 2023100003275

Decision date: 20251022

Appeal event data comment text: Appeal Kind Category : Invalidation, Appeal Ground Text : 1900520

Appeal request date: 20231011

Appellate body name: Patent Examination Board

Decision authority category: Office appeal board

Decision identifier: 2023100003293

Decision date: 20251022

Appeal event data comment text: Appeal Kind Category : Invalidation, Appeal Ground Text : 1900520

Appeal request date: 20231011

Appellate body name: Patent Examination Board

Decision authority category: Office appeal board

Decision identifier: 2023100003281

Decision date: 20251022

Appeal event data comment text: Appeal Kind Category : Invalidation, Appeal Ground Text : 1900520

Appeal request date: 20231011

Appellate body name: Patent Examination Board

Decision authority category: Office appeal board

Decision identifier: 2023100003282

V15 Decision substituted

Free format text: ST27 STATUS EVENT CODE: A-5-5-V10-V15-CRT-PJ1301 (AS PROVIDED BY THE NATIONAL OFFICE); DECISION IDENTIFIER: 2023100003280; DECISION AUTHORITY: OFFICE APPEAL BOARD, APPEAL KIND CATEGORY : INVALIDATION

Free format text: ST27 STATUS EVENT CODE: A-5-5-V10-V15-CRT-PJ1301 (AS PROVIDED BY THE NATIONAL OFFICE); DECISION IDENTIFIER: 2023100003292; DECISION AUTHORITY: OFFICE APPEAL BOARD, APPEAL KIND CATEGORY : INVALIDATION

Free format text: ST27 STATUS EVENT CODE: A-5-5-V10-V15-CRT-PJ1301 (AS PROVIDED BY THE NATIONAL OFFICE); DECISION IDENTIFIER: 2023100003291; DECISION AUTHORITY: OFFICE APPEAL BOARD, APPEAL KIND CATEGORY : INVALIDATION

Free format text: ST27 STATUS EVENT CODE: A-5-5-V10-V15-CRT-PJ1301 (AS PROVIDED BY THE NATIONAL OFFICE); DECISION IDENTIFIER: 2023100003290; DECISION AUTHORITY: OFFICE APPEAL BOARD, APPEAL KIND CATEGORY : INVALIDATION

Free format text: ST27 STATUS EVENT CODE: A-5-5-V10-V15-CRT-PJ1301 (AS PROVIDED BY THE NATIONAL OFFICE); DECISION IDENTIFIER: 2023100003289; DECISION AUTHORITY: OFFICE APPEAL BOARD, APPEAL KIND CATEGORY : INVALIDATION

Free format text: ST27 STATUS EVENT CODE: A-5-5-V10-V15-CRT-PJ1301 (AS PROVIDED BY THE NATIONAL OFFICE); DECISION IDENTIFIER: 2023100003288; DECISION AUTHORITY: OFFICE APPEAL BOARD, APPEAL KIND CATEGORY : INVALIDATION

Free format text: ST27 STATUS EVENT CODE: A-5-5-V10-V15-CRT-PJ1301 (AS PROVIDED BY THE NATIONAL OFFICE); DECISION IDENTIFIER: 2023100003287; DECISION AUTHORITY: OFFICE APPEAL BOARD, APPEAL KIND CATEGORY : INVALIDATION

Free format text: ST27 STATUS EVENT CODE: A-5-5-V10-V15-CRT-PJ1301 (AS PROVIDED BY THE NATIONAL OFFICE); DECISION IDENTIFIER: 2023100003286; DECISION AUTHORITY: OFFICE APPEAL BOARD, APPEAL KIND CATEGORY : INVALIDATION

Free format text: ST27 STATUS EVENT CODE: A-5-5-V10-V15-CRT-PJ1301 (AS PROVIDED BY THE NATIONAL OFFICE); DECISION IDENTIFIER: 2023100003285; DECISION AUTHORITY: OFFICE APPEAL BOARD, APPEAL KIND CATEGORY : INVALIDATION

Free format text: ST27 STATUS EVENT CODE: A-5-5-V10-V15-CRT-PJ1301 (AS PROVIDED BY THE NATIONAL OFFICE); DECISION IDENTIFIER: 2023100003284; DECISION AUTHORITY: OFFICE APPEAL BOARD, APPEAL KIND CATEGORY : INVALIDATION

Free format text: ST27 STATUS EVENT CODE: A-5-5-V10-V15-CRT-PJ1301 (AS PROVIDED BY THE NATIONAL OFFICE); DECISION IDENTIFIER: 2023100003283; DECISION AUTHORITY: OFFICE APPEAL BOARD, APPEAL KIND CATEGORY : INVALIDATION

Free format text: ST27 STATUS EVENT CODE: A-5-5-V10-V15-CRT-PJ1301 (AS PROVIDED BY THE NATIONAL OFFICE); DECISION IDENTIFIER: 2023100003275; DECISION AUTHORITY: OFFICE APPEAL BOARD, APPEAL KIND CATEGORY : INVALIDATION

Free format text: ST27 STATUS EVENT CODE: A-5-5-V10-V15-CRT-PJ1301 (AS PROVIDED BY THE NATIONAL OFFICE); DECISION IDENTIFIER: 2023100003293; DECISION AUTHORITY: OFFICE APPEAL BOARD, APPEAL KIND CATEGORY : INVALIDATION

Free format text: ST27 STATUS EVENT CODE: A-5-5-V10-V15-CRT-PJ1301 (AS PROVIDED BY THE NATIONAL OFFICE); DECISION IDENTIFIER: 2023100003281; DECISION AUTHORITY: OFFICE APPEAL BOARD, APPEAL KIND CATEGORY : INVALIDATION

Free format text: ST27 STATUS EVENT CODE: A-5-5-V10-V15-CRT-PJ1301 (AS PROVIDED BY THE NATIONAL OFFICE); DECISION IDENTIFIER: 2023100003282; DECISION AUTHORITY: OFFICE APPEAL BOARD, APPEAL KIND CATEGORY : INVALIDATION

PJ0202 Trial for correction

St.27 status event code: A-5-5-V10-V11-apl-PJ0202

V11 Administrative appeal requested

Free format text: ST27 STATUS EVENT CODE: A-5-5-V10-V11-APL-PJ0202 (AS PROVIDED BY THE NATIONAL OFFICE)